Portfolio company
Outpost
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
The company develops microbiome models using machine learning to help drug and food research teams predict biological interactions and assess development risks.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Outpost Bio
This company builds machine learning models of the human microbiome to help pharmaceutical and consumer health teams predict drug interactions and ingredient efficacy.
Anto
This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.
Anto Biosciences
This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.
Pragma Biosciences
This company develops a drug discovery platform using machine learning to identify microbiome-derived small molecules for pharmaceutical and healthcare partners.
Outpace
This biotechnology company develops custom protein-based biological software to create smart cell therapies for patients with cancer and autoimmune diseases.
Pragma Bio
This company develops a machine learning platform to discover and manufacture microbiome-derived small molecule medicines for patients with immunological disorders and cancer.
Basecamp Research
This company develops AI models and genomic datasets to design therapeutics for pharmaceutical and biotechnology partners.
BioCorteX
This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.
